News

All current DZIF news can be found here.

Epstein Barr virus in cells
© CDC/Dr. P. Feorino

Epstein-Barr virus: DZIF and Helmholtz Munich working on a vaccine

The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. DZIF scientists at

Ulrike Protzer
© TUM/Astrid Eckert; Hintergrund: cdc

Ulrike Protzer is awarded the DZIF Prize for Translational Infection Research

This year, the German Center for Infection Research (DZIF) is honouring the medical scientist and clinical virologist Prof. Ulrike Protzer for her scientific achievements. The prize is endowed with

Lab-Training in Benin
© Michael Nagel

The Delta variant of SARS-CoV-2 is rapidly taking over in West Africa

While the highly infectious SARS-CoV-2 Delta variant has already become predominant in Germany and in most European nations, little was known about its spread in Africa. German Center for Infection

Klebsiella pneumoniae
© NIAID

Quest for bacterial cocktails to fight infections

The intestine of a healthy person contains hundreds of different bacteria that provide efficient protection against infections. However, if the equilibrium of this community, known as the microbiota

Escherichia coli
© NIAID

Alarming: Resistances against a new active-substance combination detectable prior to use in Germany

Enterobacteria such as Escherichia coli or Klebsiella pneumoniae are dreaded hospital germs that can cause serious intestinal and urinary tract infections. The risk of infection with these pathogens

Julia Pagel Preisverleihung
© C. Kloodt / Exzellenzcluster PMI, Uni Kiel

Julia Pagel honoured with the Dorothea Erxleben Female Investigator Award

Paediatrician and DZIF scientist Dr Julia Pagel, Universität zu Lübeck, will receive EUR 50,000 to expand her research on lung diseases in infants. The prize is awarded by the North German Cluster of

Pipeline für neue Antibiotika
© mod. nach Nat Rev Chem (2021): https://doi.org/10.1038/s41570-021-00313-1

Fighting resistances: Concepts for new antibiotics

Increasingly insensitive to standard drugs: Multi-resistant pathogens are spreading worldwide and even in the near future could threaten the safe treatment of deadly infectious diseases. However, the

Impfstoffe
© fernando zhiminaicela auf Pixabay

Combination vaccines against Covid-19 tested

People under the age of 60 who initially received a vaccine from AstraZeneca should be given an mRNA vaccine at their second appointment. This is recommended by the German Standing Committee on

Acetat aktiviert das Immunsystem
© Universität Tübingen, Michael Pelzer

Tübingen research team develops new strategy against sepsis

Some cases of bloodstream infections are mild, but many have a fatal outcome – the reasons for these differences have remained in the dark despite decades of research. Researchers from the University

idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

Study with optimized vector vaccine MVA-SARS-2-S resumed

The clinical review of the MVA-SARS-2-S vector vaccine against COVID-19 will continue with a new version. The DZIF (German Center for Infection Research) scientists temporarily suspended the study